UBS Group’s Ovid Therapeutics OVID Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.15K Sell
21,669
-5,289
-20% -$1.75K ﹤0.01% 7719
2025
Q1
$8.41K Sell
26,958
-33,809
-56% -$10.5K ﹤0.01% 7443
2024
Q4
$56.8K Buy
60,767
+30,155
+99% +$28.2K ﹤0.01% 6002
2024
Q3
$36.1K Buy
30,612
+9,420
+44% +$11.1K ﹤0.01% 5831
2024
Q2
$16.3K Sell
21,192
-52,230
-71% -$40.2K ﹤0.01% 6285
2024
Q1
$224K Buy
73,422
+1,489
+2% +$4.54K ﹤0.01% 4638
2023
Q4
$232K Buy
71,933
+23,826
+50% +$76.7K ﹤0.01% 4522
2023
Q3
$185K Sell
48,107
-1,519
-3% -$5.83K ﹤0.01% 4312
2023
Q2
$163K Buy
49,626
+31,557
+175% +$104K ﹤0.01% 4585
2023
Q1
$46.6K Buy
18,069
+1,276
+8% +$3.29K ﹤0.01% 5425
2022
Q4
$31.2K Sell
16,793
-2,368
-12% -$4.4K ﹤0.01% 6030
2022
Q3
$36K Buy
19,161
+3,216
+20% +$6.04K ﹤0.01% 5584
2022
Q2
$34K Buy
15,945
+945
+6% +$2.02K ﹤0.01% 5244
2022
Q1
$47K Sell
15,000
-4,277
-22% -$13.4K ﹤0.01% 5539
2021
Q4
$62K Buy
19,277
+4,277
+29% +$13.8K ﹤0.01% 5634
2021
Q3
$50K Hold
15,000
﹤0.01% 5228
2021
Q2
$59K Sell
15,000
-5,037
-25% -$19.8K ﹤0.01% 5233
2021
Q1
$81K Sell
20,037
-1,009,556
-98% -$4.08M ﹤0.01% 5133
2020
Q4
$2.38M Buy
1,029,593
+579,322
+129% +$1.34M ﹤0.01% 2496
2020
Q3
$2.58M Buy
450,271
+317,281
+239% +$1.82M ﹤0.01% 2210
2020
Q2
$980K Sell
132,990
-74,974
-36% -$552K ﹤0.01% 2831
2020
Q1
$620K Buy
207,964
+203,986
+5,128% +$608K ﹤0.01% 3033
2019
Q4
$17K Buy
+3,978
New +$17K ﹤0.01% 5925
2019
Q3
Sell
-6,860
Closed -$13K 7110
2019
Q2
$13K Buy
+6,860
New +$13K ﹤0.01% 6023
2019
Q1
Sell
-10,101
Closed -$24K 7032
2018
Q4
$24K Buy
10,101
+6,805
+206% +$16.2K ﹤0.01% 5726
2018
Q3
$19K Buy
3,296
+322
+11% +$1.86K ﹤0.01% 5909
2018
Q2
$23K Buy
+2,974
New +$23K ﹤0.01% 5686
2018
Q1
Sell
-227
Closed -$2K 7013
2017
Q4
$2K Sell
227
-1,543
-87% -$13.6K ﹤0.01% 6634
2017
Q3
$15K Buy
+1,770
New +$15K ﹤0.01% 5748